Description
AOD9604 is a synthetic peptide fragment derived from the C-terminal domain of human growth hormone (hGH), encompassing amino acids 177-191. This peptide is a modified version of the natural hormone’s lipolytic region, which is responsible for its fat-burning effects. Research suggests that AOD9604 stimulates lipolysis—the breakdown of fats and other lipids—and inhibits lipogenesis, the metabolic process of forming fat. This dual action makes it a significant subject of interest in obesity research. Unlike hGH, AOD9604 does not appear to induce hyperglycemia or affect insulin sensitivity, making it a potentially safer therapeutic candidate. Key research areas for AOD9604 include its application in managing obesity, improving lipid profiles, and its potential role in cartilage and bone repair. Studies have indicated a strong safety and tolerability profile in human clinical trials. This product is intended for laboratory research use only and is not for human or veterinary use.
CAS: 221231-10-3
PubChem CID: 71300630
Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂
Molecular Weight: 1815.1 g/mol
Amino Acid Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (16 aa)
Physical Form: Lyophilized Powder
Purity: ≥99%
Storage: -20°C, protected from light and moisture
